Every Month: 5 Days On, 2 Days Off The injection schedule is consistent across all three months: inject for 5 consecutive days, rest for 2, then repeat
Telomere Shortening You can think of telomeres as protective caps on the ends of your chromosomes, kind of like the plastic tips on shoelaces
Karam et al
Approval: 2014 Indications and Usage for Farxiga FARXIGA is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated: To reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular (CV) death, and hospitalization for heart failure in adults with chronic kidney disease at risk of progression
Loss of lean body mass, especially muscle, can contribute to frailty, sarcopenia and metabolic decline, all of which are particularly troubling in aging populations or individuals with low baseline muscle mass